Socialiya - Entertainment. Knowledge. Community.
AACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises

After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last...

BUSINESS NEWS April 21, 2026

AACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises

After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last week, Revolution Medicines is not resting on its laurels...

13 views 0 likes 0 comments
Share:
After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last week, Revolution Medicines is not resting on its laurels...

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
APNA POS
Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
APNA POS
Advertisement
APNA POS